[1] LÓPEZ DE MUNAIN A,BLANCO A,EMPARANZA JI,et al.Prevalence of myotonic dystrophy in Guipúzcoa (Basque Country,Spain)[J].Neurology,1993,43(8):1573.
[2] MATEOS-AIERDI AJ,GOICOECHEA M,AIASTUI A,et al.Muscle wasting in myotonic dystrophies:a model of premature aging[J].Front Aging Neurosci,2015,7(125):1.
[3] PETTERSSON OJ,AAGAARD L,JENSEN TG,et al.Molecular mechanisms in DM1-a focus on foci[J].Nucleic Acids Res,2015,43(4):2433.
[4] BROOK JD,MCCURRACH ME,HARLEY HG,et al.Molecular basis of myotonic dystrophy:expansion of a trinucleotide(CTG) repeat at the 3-prime end of a transcript encoding a protein kinase family member[J].Cell,1992,68(4):799.
[5] TURNER C,HILTON-JONES D.Myotonic dystrophy:diagnosis,management and new therapies[J].Curr Opin Neurol,2014,27(5):599.
[6] CHRISTINA LL,KENNETH R,MELINDA LM,et al.Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9[J].Science,2001,293(5531):864.
[7] LE BER I,MARTINEZ M,CAMPION D,et al.A non-DM1,non-DM2 multisystem myotonic disorder with frontotemporal dementia:phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24[J].Brain,2004,127(Pt9):1979.
[8] MACHUCA-TZILI L,BROOK D,HILTON-JONES D,et al.Clinical and molecular aspects of the myotonic dystrophies:a review[J].Muscle Nerve,2005,32(1):1.
[9] NOJSZEWSKA M,LUSAKOWSKA A,SZMIDT-SALKOWSKA E,et al.Peripheral nerve involvement in myotonic dystrophy type2-similar or different than in myotonic dystrophy type 1?[J].Neurol Neurochir Pol,2015,49(3):164.
[10] DAY JW,RICKER K,JACOBSEN JF,et al.Myotonic dystrophy type 2:molecular,diagnostic and clinical spectrum[J].Neurology,2003,60(4):657.
[11] THORNTON CA.Myotonic dystrophy[J].Neurol Clin,2014,32(3):705.
[12]
[13] PONGRATZ D,SCHULTZ D,KOPPENWALLNER C,et al.Diagnostic value of muscle biopsy findings in myotonic dystrophyÓ (Curschmann-Steinert) (author's transl)[J].Klin Wochenschr,1979,57(5):215.